214 | Linking oncologic drug price to its value: the Italian proposal for a solution Gozzo L., Navarria A., Drago V., Longo L., Mansueto S., Cicchetti A., Drago F. |
213 | Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”: A Novel Measure for Cost-Containment of Drug Expenditure Navarria A., Drago V., Gozzo L., Longo L., Mansueto S., Pignataro G., Drago F. |
315 | Drug repurposing platform for new targets/new indications search Bartella C., Corso G., Garofalo B., Mangano G., Ombrato R., Alisi MA. |
624 | Pharmacoeconomic evaluation of genetic profiling to prevent FOLFIRI-induced toxicities in mCRC patient Roncato R., Cecchin E., Montico M., Buonadonna A., De Mattia E., Giodini L., Gagno S., Dreussi E., Toffoli G. |
662 | Ethics in pharmacological treatments: prospects and social philosophy for a fair access to innovation
Bernardini R., Sciacca F., Russo P., Di Mauro R., Recchia G., Muzzio CC., Cantarella G., Veca S. |
170 | Switching and cost of treatment in patients with gastrointestinal or rheumatic diseases chronically treated with biological agents: regional data through administrative database analysis Romero M., Pellicciotta E., Cinque S., Di Iorio P. |
631 | Acute epigastric pain and liver toxicity associated with acetaminophen-codeine use in cholecystectomized patients Moschini M., Lenti MC., Bonaiuti R., Giovannelli L., Lombardi N., Lucenteforte E., Leone R., Maggini V., Pugi A., Gallo E., Mugelli A., Vannacci A. |
63 | Health needs assessment in low income patients assisted by pharmaceutical charitable organisations: a preliminary survey based on the analysis of drug dispensation Bini S., Fiorini G., Bertazzi P., Rigamonti AE., Cella SG. |
629 | Ticagrelor-related dyspnea in patients with acute coronary syndrome: a three year cohort study Lucenteforte E., Lombardi N., Barchielli A., Torrini M., Mugelli A., Vannacci A. |